HomeInsights Hub Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?
Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?
July 31, 2018
The next generation of relationship holders will offer highly personalised services.
Immuno-oncology agents have made a space for themselves as the ‘fourth pillar’ of cancer therapy with some stunning clinical results.
